Switch to
More onapp

How to use scorecard? Learn more

Solara Active Pharma Sciences Ltd

SOLARA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,276 cr, stock is ranked 994
High RiskStock is 3.25x as volatile as Nifty
356.051.50 (+0.42%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't faired well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,276 cr, stock is ranked 994
High RiskStock is 3.25x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-57.57
PB RatioPB Ratio
0.84
Dividend YieldDiv. Yield
Sector PESector PE
34.42
Sector PBSector PB
4.62
Sector Div YldSctr Div Yld
0.81%

Forecast & RatingsDetailed Forecast 

75%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

SSL Pharma Sciences is a manufacturer of pharmaceutical preparation

Financial TrendFinancial statements 

20202021202220231.351.651.291.470.110.22-0.06-0.02
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Annual Secretarial Compliance Report 
Announced OnMay 25, 2023

Annual Secretarial Compliance Report for the financial year 2022-23 | Download

Annual Secretarial Compliance Report for the financial year 2022-23 | Download

Disclosure under SEBI Takeover Regulations 
Announced OnMay 23, 2023

Solara Active Pharma Sciences Limitedᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ᅡᅠ | Download

Solara Active Pharma Sciences Limitedᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ᅡᅠ | Download

Cash Dividend 
Ex. DateAug 18, 2021

Final • Div/Share: ₹ 3

See all events